{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:43:27Z","timestamp":1794534207155,"version":"4.9.1"},"reference-count":33,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Accurate diagnosis of B-cell chronic lymphoproliferative disorders (B-CLPDs) remains challenging due to overlapping phenotypes across subtypes. Machine learning (ML) offers promising tools to improve marker evaluation and refine flow cytometry analysis. We investigated the use of ML algorithms to evaluate the diagnostic value of incorporating CD148, CD180, and CD200 into standard B-CLPD phenotyping panel and to develop a diagnosis decision tree. We trained models with flow cytometry data from 480 patients with B-CLPDs using XGBoost and DecisionTree algorithms. The final models integrated 2 categorical markers (CD5 and CD10) and quantiles of fluorescence intensity of 4 quantitative markers (CD20, CD180, and CD200) to classify 6 B-CLPD subtypes. These trained models were applied to an independent cohort of 433 patients with B-CLPD analyzed on a different flow cytometer platform. DecisionTree models achieved the highest classification accuracy (mean accuracy, 0.88) in the validation cohort. The overall specificity ranged from 0.95 lymphoplasmacytic lymphoma (LPL) to 1 hairy cell leukemia (HCL), whereas sensitivity varied from 0.75 (LPL) to 1 (HCL). The DecisionTree model demonstrated superior identification of chronic lymphocytic leukemia compared to a Matutes score of 4 or 5 (P = .029). In more than half of the cases, a diagnosis was determined with near certainty using only the cytometry data. For the remaining cases, a hierarchical approach incorporating additional tests was proposed. For practical implementation, an interactive interface provides diagnostic predictions, positive predictive values, and Gini index scores. This study establishes a ML-optimized strategy for B-CLPD classification, combining phenotypic, cytogenetic, and molecular data to enhance diagnostic accuracy of leukemic B-CLPD cells. This trial was registered at www.ClinicalTrials.gov as #NCT04952974.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016424","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:31:42Z","timestamp":1763137902000},"page":"5880-5887","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Artificial intelligence\u2013based flow cytometry for the diagnosis of B-cell chronic lymphoproliferative disorders"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-1845","authenticated-orcid":false,"given":"Laurent","family":"Mauvieux","sequence":"first","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"2Immunologie, Immunopathologie et Chimie Th\u00e9rapeutique, CNRS UPR3572, IBMC, Strasbourg, France"},{"name":"3University of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, Strasbourg, France"},{"name":"4Department of Hematology, Institut de Canc\u00e9rologie Strasbourg Europe, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Eischen","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-C\u00e9cile","family":"Galoisy","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7801-6534","authenticated-orcid":false,"given":"Delphine","family":"Rolland","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"3University of Strasbourg, Strasbourg, France"},{"name":"5Laboratoire de Spectrom\u00e9trie de Masse Bio-Organique, Institut Pluridisciplinaire Hubert Curien, UMR 7178, CNRS, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Gervais","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-3694","authenticated-orcid":false,"given":"Caroline","family":"Mayeur-Rousse","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hueber-Bonnot","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Nicolae","sequence":"additional","affiliation":[{"name":"2Immunologie, Immunopathologie et Chimie Th\u00e9rapeutique, CNRS UPR3572, IBMC, Strasbourg, France"},{"name":"3University of Strasbourg, Strasbourg, France"},{"name":"6Department of Pathology, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc-Matthieu","family":"Fornecker","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, Strasbourg, France"},{"name":"4Department of Hematology, Institut de Canc\u00e9rologie Strasbourg Europe, Strasbourg, France"},{"name":"5Laboratoire de Spectrom\u00e9trie de Masse Bio-Organique, Institut Pluridisciplinaire Hubert Curien, UMR 7178, CNRS, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-203X","authenticated-orcid":false,"given":"Thibaut","family":"Goetsch","sequence":"additional","affiliation":[{"name":"7Department of Public Health, GMRC, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Severac","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, Strasbourg, France"},{"name":"7Department of Public Health, GMRC, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Bizo\u00ef","sequence":"additional","affiliation":[{"name":"8DBSYS SAS, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Fabacher","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, Strasbourg, France"},{"name":"7Department of Public Health, GMRC, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Miguet","sequence":"additional","affiliation":[{"name":"1Hematology Clinical Laboratory, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"2Immunologie, Immunopathologie et Chimie Th\u00e9rapeutique, CNRS UPR3572, IBMC, Strasbourg, France"},{"name":"3University of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"9","key":"2025112509112762300_bib1","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"2025112509112762300_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.htct.2019.07.006","article-title":"Multidisciplinary diagnostics of chronic lymphocytic leukemia: European research initiative on CLL - ERIC recommendations","volume":"42","author":"Zalcberg","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"issue":"11","key":"2025112509112762300_bib3","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"2025112509112762300_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2021.11.001","article-title":"Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall","volume":"119","author":"Qiu","year":"2022","journal-title":"Hum Pathol"},{"issue":"1","key":"2025112509112762300_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1309\/AJCPPAG4VR4IPGHZ","article-title":"Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias","volume":"131","author":"Ho","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"2025112509112762300_bib6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.MP.0000031710.32235.24","article-title":"Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation","volume":"15","author":"Nelson","year":"2002","journal-title":"Mod Pathol"},{"issue":"10","key":"2025112509112762300_bib7","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"issue":"suppl 1","key":"2025112509112762300_bib8","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2025112509112762300_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-023-00682-x","article-title":"The role of CD180 in hematological malignancies and inflammatory disorders","volume":"29","author":"Edwards","year":"2023","journal-title":"Mol Med"},{"issue":"5","key":"2025112509112762300_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/ijlh.13467","article-title":"The relative expression levels of CD148 and CD180 on clonal B cells and CD148\/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - results from a single centre pilot study","volume":"43","author":"Gautam","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"13","key":"2025112509112762300_bib11","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/cam4.3983","article-title":"A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia","volume":"10","author":"Li","year":"2021","journal-title":"Cancer Med"},{"issue":"1","key":"2025112509112762300_bib12","doi-asserted-by":"crossref","first-page":"e3245","DOI":"10.1002\/hon.3245","article-title":"Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data","volume":"42","author":"Gross","year":"2024","journal-title":"Hematol Oncol"},{"issue":"7","key":"2025112509112762300_bib13","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1021\/pr801102c","article-title":"Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis","volume":"8","author":"Miguet","year":"2009","journal-title":"J Proteome Res"},{"issue":"12","key":"2025112509112762300_bib14","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.3109\/10428194.2015.1030642","article-title":"Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis","volume":"56","author":"Fan","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2025112509112762300_bib15","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/leu.2013.3","article-title":"Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas","volume":"27","author":"Miguet","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"2025112509112762300_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cyto.b.21325","article-title":"CD180 expression in B-cell lymphomas: a multicenter GEIL study","volume":"90","author":"Mayeur-Rousse","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"2025112509112762300_bib17","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/ijlh.12824","article-title":"Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL","volume":"40","author":"Favre","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"2025112509112762300_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"CD200 (OX-2 membrane glycoprotein) expression in b cell-derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"2025112509112762300_bib19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"issue":"4","key":"2025112509112762300_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ajcp\/aqaa166","article-title":"Augmented human intelligence and automated diagnosis in flow cytometry for hematologic malignancies","volume":"155","author":"Ng","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2025112509112762300_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cyto.b.22168","article-title":"MAGIC-DR: an interpretable machine-learning guided approach for acute myeloid leukemia measurable residual disease analysis","volume":"106","author":"Shopsowitz","year":"2024","journal-title":"Cytometry B Clin Cytom"},{"key":"2025112509112762300_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"jair"},{"key":"2025112509112762300_bib23","unstructured":"Le Guyader-Peyrou\n              S\n            , DefossezG, DantonyE, . Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018 - H\u00e9mopathies malignes: \u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim. INSERM. 2019. Accessed 5 July 2019. https:\/\/www.santepubliquefrance.fr\/docs\/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-volume-2-hemopathies-malignes."},{"key":"2025112509112762300_bib24","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Machine Learn Res"},{"key":"2025112509112762300_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1145\/2939672.2939785","volume-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","author":"Chen","year":"2016"},{"key":"2025112509112762300_bib26","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1109\/TIFS.2021.3076932","article-title":"Gini-impurity index analysis","volume":"16","author":"Yuan","year":"2021","journal-title":"IEEE Trans Inf Forensics Secur"},{"issue":"4","key":"2025112509112762300_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/10428194.2021.2002317","article-title":"CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage","volume":"63","author":"Soleimani","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2025112509112762300_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/alr.21924","article-title":"Discordant frequencies of tissue-resident and circulating CD180-negative B cells in chronic rhinosinusitis","volume":"7","author":"Miljkovic","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"2025112509112762300_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cyto.b.21331","article-title":"CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment","volume":"90","author":"Mestrallet","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"2025112509112762300_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.semnuclmed.2022.11.003","article-title":"Role of artificial intelligence in PET\/CT imaging for management of lymphoma","volume":"53","author":"Veziroglu","year":"2023","journal-title":"Semin Nucl Med"},{"issue":"6","key":"2025112509112762300_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PAP.0000000000000277","article-title":"Artificial intelligence in pathology: a simple and practical guide","volume":"27","author":"Yao","year":"2020","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"2025112509112762300_bib32","doi-asserted-by":"crossref","first-page":"101384","DOI":"10.1016\/j.beha.2022.101384","article-title":"SARS-CoV-2 primary and breakthrough infections in patients with cancer: implications for patient care","volume":"35","author":"Wang","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"2025112509112762300_bib33","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41591-023-02482-6","article-title":"Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary","volume":"29","author":"Moon","year":"2023","journal-title":"Nat Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/22\/5880\/2420538\/blooda_adv-2025-016424-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/22\/5880\/2420538\/blooda_adv-2025-016424-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:11:40Z","timestamp":1764079900000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/22\/5880\/548179\/Artificial-intelligence-based-flow-cytometry-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":33,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,11,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016424","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,25]]},"published":{"date-parts":[[2025,11,14]]}}}